ObsEva

$3.05
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.08 (-2.56%) Today
+$0.01 (+0.33%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ObsEva and other stocks, options, and ETFs commission-free!

About OBSV

ObsEva SA Ordinary Shares, also called ObsEva, is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic treatments for woman's reproductive health and pregnancy. It offers biopharmaceutical drugs addressing conditions compromising pregnancy from conception to birth.

CEO
Brian O'Callaghan
Employees
42
Headquarters
Geneva, Geneve (Geneva)
Founded
2012
Market Cap
265.71M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
860.58K
High Today
$3.14
Low Today
$3.03
Open Price
$3.11
Volume
701.12K
52 Week High
$6.30
52 Week Low
$1.86

OBSV Earnings

-$0.63
-$0.42
-$0.21
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 4, Pre-Market

You May Also Like

LGLV
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure